Nakashima, K., Demura, Y., Oi, M., Tabata, M., Tada, T., Shiozaki, K., . . . Ishizuka, T. (2020). Infliximab Was Found to Be Effective for Treating Immunosuppressive Drug-resistant Hepatitis due to Durvalumab. Intern Med.
Citação norma ChicagoNakashima, Koki, Yoshiki Demura, Masahiro Oi, Mio Tabata, Toshihiko Tada, Kohei Shiozaki, Masaya Akai, and Tamotsu Ishizuka. "Infliximab Was Found to Be Effective for Treating Immunosuppressive Drug-resistant Hepatitis Due to Durvalumab." Intern Med 2020.
Citação norma MLANakashima, Koki, et al. "Infliximab Was Found to Be Effective for Treating Immunosuppressive Drug-resistant Hepatitis Due to Durvalumab." Intern Med 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.